December #140 : New Resistance Fighters

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents
 

Precious Stone

More Than Just a Number




Dodging Danger

Northern Disclosure

Ask For It By Name

Learning Latex

Yule Love ’Em

Catch of the Month

Cash Therapy

A Wealth of Trouble

Think Inside the Box

Baby Bonus

New Resistance Fighters




African in America

Windy City Blues

Unfine China

It’s a Wrap

Hot Dates-December 2007

Wake Up, India

Survey Says...

Clean Sweep

Look Elsewhere

Yesterday Once More

A Day Without “Day Without Art”

Medicine Man

Suspicious Minds




Editor's Letter-December 2007

Mailbox-December 2007



 
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


Scroll down to comment on this story.


email print

December 2007


New Resistance Fighters

The FDA has approved two new drugs, Pfizer’s Selzentry (maraviroc) and Merck’s Isentress (raltegravir), for HIV that’s resistant to other meds. The newcomers hit fresh viral targets—Selzentry blocks a protein (CCR5) on immune cells and prevents HIV entry; Merck’s integrase inhibitor halts HIV’s hijacking of CD4 cells’ DNA. Both worked well in studies, especially when combined with other meds to which HIV is still sensitive. Experts expect even better things for treatment veterans using the two new drugs together. For more info, check out AIDSmeds.com. 


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]

Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    aqua_31206
    Macon
    Georgia


    newlife202
    JOLIET
    Illinois


    TaintedloveDC
    Washington
    DC


    albsur7436
    San Francisco
    California
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.